Company applying novel, high-throughput screening technologies to DELIVER therapeutics that address the most difficult problems in clinical medicine Rapha Capital BioVentures Fund I Leads Convertible Note Financing to initiate operations MIAMI, Dec. 14, 2021 /PRNewswire/ — DELIVER…
MODI’IN, ISRAEL, ISRAEL, December 8, 2021 /EINPresswire.com Total financing for market launch and penetration surpasses $9 million mark Breakthrough “FIZE kUO™” device for monitoring real-time kidney urine output to enter…
Vancouver, B.C. and Boston, MA, November 8, 2021 – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) “Imagin” or the “Company”), a surgical imaging company visualizing cancer in vital new ways…
Rapha Capital BioVentures Fund I, LP (RCBVFI) managed by Rapha Capital leads the financing. Kevin Slawin, M.D., a leading urooncologist and manager of RCBVFI, joins the board. Imagin Medical’s i/Blue™…
Rapha Capital BioVentures Fund I, LP (RCBVFI), Leads New Convertible Note Financing Kevin Slawin, MD, a Leading UroOncologist and Manager of RCBVFI Joins the Board Imagin Medical’s i/Blue™ Imaging System is Poised to…